FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3142331256> ?p ?o ?g. }

• W3142331256 abstract "Hertz et al. (2015) provided data indicating that the indisputable SERT inhibition caused by SSRIs is an epiphenomenon. Instead we pointed toward acute and chronic effects of fluoxetine on 5-HT2B receptor stimulation in astrocytes (in culture or freshly isolated from brains of mice treated with fluoxetine for 14 days). Stimulation by fluoxetine of the astrocytic 5-HT2B receptor causes a multitude of effects that in astrocyte cultures could be prevented by drug- or siRNA-induced 5-HT2B receptor inhibition (Figure ​(Figure1).1). This stimulation activates complex signaling pathways, including EGF receptor transactivation, a signal pathway in which a G-protein-coupled receptor (GPCR) signal leads to release of a growth factor, which activates the EGF receptor-tyrosinekinase in the same or adjacent cells. Astrocytes express a number of GPCRs and play key roles in brain function (Hansson and Ronnback, 2004; Fields, 2009). The autocrine effects of growth factor release may regulate gene expression and alter cell functions in the astrocytes themselves and the paracrine effects provide opportunities for effects on their neuronal neighbors. Our studies in mice treated with fluoxetine for 2 weeks showed multiple gene upregulations and editings (Li et al., 2012; Hertz et al., 2015), which altered the function of the gene product in kainate receptors, 5-HT2 receptors, phospholipase cPLA2, a Ca2+ L-channel gene and nucleoside transporter genes. These changes occurred mainly in astrocytes but some were neuronal. They occurred together with effects on metabolism of glucose and glycogen and turnover of glutamate and GABA, consistent with evidence of increased glutamatergic activity and decreased GABA-ergic activity in patients suffering from major depression, which are reverted by successful therapy; similarly, glucose metabolism is decreased in depressed patients and increases following treatment (Hertz et al., 2015).Figure 1Phosphorylation of ERK1∕2, a known target of 5-HT2B receptor stimulation in astrocytes. After treatment with phosphate-buffered saline, PBS (Control), transfection solution without siRNA (siRNA (−)) or siRNA specific to 5-HT2B receptor ...A commentary by Banas et al. (2015) claim that we forgot important information provided by Diaz et al. (2012), including absence of antidepressant effects of fluoxetine or the 5-HT2B agonist BW723C86 in mice lacking the serotonin transporter (SERT) or differentiated serotonergic neurons. They allege that these data rule out that the antidepressant effects of fluoxetine or BW723C86 could be SERT-independent (as claimed by us) and show that serotonergic neurons expressing SERT are necessary for the 5-HT2B receptor effects exerted by fluoxetine (and other 5-HT2B receptor agonists). They further remind us that Launay et al. (2006) in neuronal cultures from raphe nuclei demonstrated 5-HT2B receptor-mediated control of SERT activity via 5-HT2B receptor-promoted SERT phosphorylations. This should explain the finding by Diaz et al. (2012) that there are no antidepressant effects of either fluoxetine or BW723C86 in mice knocked-out for SERT or lacking differentiated serotonin neurons. These data should also rule out that the antidepressant effects of 5-HT2B agonists, including fluoxetine, could be independent of SERT and explain the conclusion by the Maroteaux group (Diaz et al., 2012) that fluoxetine acts by 5-HT2B receptor-mediated regulation of SERT in a cell autonomous manner.We were well aware of the lack of antidepressant effect in SERT knock-outs described by Diaz et al. (2012) and of their reference to the paper by Launay et al. (2006), but did not comment on these points, because they are irrelevant. The lack of effect in the knock-outs does not prove any dependence on SERT, because Qu et al. (2005) showed that the direct DOI-mediated stimulation of 5-HT2 receptor activation of phospholipase A2 (cPLA2) and subsequent arachidonic acid release and metabolism seen in normal mice is abolished in mice lacking SERT. There is no information in the literature that DOI should interact with SERT. Although Qu et al. indicated DOI as a 5-HT2A∕C agonist it also activates the 5-HT2B receptor (Pineda-Farias et al., 2015). Stimulation of this receptor is the most likely reason for the response in wild-type animals, because fluoxetine acutely stimulates astrocytic 5-HT2B receptors in cultured astrocytes (Li et al., 2008; Qiao et al., 2015) and after chronic administration (14 days) to mice upregulates this receptor in astrocytes but not in neurons (Li et al., 2012; Hertz et al., 2015). Moreover, cPLA2-mediated signal transduction is increased by acute fluoxetine administration in unanesthetized rats (Qu et al., 2003) and phospholipase A2 activity is potently stimulated by the SSRI sertraline in yeast (Rainey et al., 2010). Since direct stimulation with an agonist has no effect in these animals, the lack of fluoxetine effect in the knockouts does not prove fluoxetine dependence on SERT in adult brain.With respect to the paper by Launay et al. it 2006 deals with extremely young cells. It does therefore not show that fluoxetine stimulates the 5-HT2B receptor in mature individuals, because Homberg et al. (2011) and Sarkar et al. (2014) have shown that the serotonergic system in the immature brain functions in a completely different manner than in the mature brain.Banas et al. also claim we changed results. However, the figure in Hertz et al. (2012) and in Kong et al. (2002) is—of course—the same and any reader has the opportunity to calculate Ki values based on the graph and the concentrations of mesulergine. The Zhang et al. (2010) paper, referred to in the Banas commentary clearly indicates the difference between SSRI affinity during acute and chronic treatment. There is no major difference between the acute affinity found by ourselves and others, and we are the only authors who have measured affinities for SSRIs in chronically treated cells. The suggestion that effects on muscarinic acetylcholine and histamine receptors or other monoamine transporters should explain our observations independently of “putative” direct agonist effects at 5-HT2B receptors is invalidated by the observation by Li et al. (2008) that “ERK phosphorylation was abolished by SB204741, a universal 5-HT2 receptor antagonist, and in 5-HT2B receptor-depleted cells (see Figure ​Figure1),1), but unaffected by 5-HT2A or 5-HT2C receptor antagonists.” Fluoxetine stimulation of astrocytic 5-HT2B receptors was confirmed by Qiao et al. (2015). The “putative” receptors were demonstrated on both well-differentiated astrocyte cultures and freshly isolated astrocytes (Li et al., 2008, 2012; Peng et al., 2010; Zhang et al., 2010).The commentary by Banas et al. has accordingly not altered our original conclusions but rather strengthened it." @default.
• W3142331256 created "2021-04-13" @default.
• W3142331256 creator A5006219225 @default.
• W3142331256 creator A5022130217 @default.
• W3142331256 creator A5046602530 @default.
• W3142331256 creator A5061796601 @default.
• W3142331256 date "2015-11-13" @default.
• W3142331256 modified "2023-09-24" @default.
• W3142331256 title "Response: Commentary: Chronic SSRI Stimulation of Astrocytic 5-HT2B Receptors Change Multiple Gene Expressions/Editings and Metabolism of Glutamate, Glucose and Glycogen: A Potential Paradigm Shift" @default.
• W3142331256 cites W1511068333 @default.
• W3142331256 cites W1962010571 @default.
• W3142331256 cites W1980673850 @default.
• W3142331256 cites W2001283999 @default.
• W3142331256 cites W2030698030 @default.
• W3142331256 cites W2031733304 @default.
• W3142331256 cites W2039566040 @default.
• W3142331256 cites W2040857878 @default.
• W3142331256 cites W2066669212 @default.
• W3142331256 cites W2071741585 @default.
• W3142331256 cites W2099511581 @default.
• W3142331256 cites W2109636493 @default.
• W3142331256 cites W2132234084 @default.
• W3142331256 cites W2319365136 @default.
• W3142331256 cites W2323397639 @default.
• W3142331256 cites W269293841 @default.
• W3142331256 cites W3140244058 @default.
• W3142331256 doi "https://doi.org/10.3389/fnbeh.2015.00308" @default.
• W3142331256 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4643646" @default.
• W3142331256 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26617504" @default.
• W3142331256 hasPublicationYear "2015" @default.
• W3142331256 type Work @default.
• W3142331256 sameAs 3142331256 @default.
• W3142331256 citedByCount "1" @default.
• W3142331256 countsByYear W31423312562016 @default.
• W3142331256 crossrefType "journal-article" @default.
• W3142331256 hasAuthorship W3142331256A5006219225 @default.
• W3142331256 hasAuthorship W3142331256A5022130217 @default.
• W3142331256 hasAuthorship W3142331256A5046602530 @default.
• W3142331256 hasAuthorship W3142331256A5061796601 @default.
• W3142331256 hasBestOaLocation W31423312561 @default.
• W3142331256 hasConcept C126322002 @default.
• W3142331256 hasConcept C134018914 @default.
• W3142331256 hasConcept C169760540 @default.
• W3142331256 hasConcept C170493617 @default.
• W3142331256 hasConcept C192118531 @default.
• W3142331256 hasConcept C24998067 @default.
• W3142331256 hasConcept C2777499176 @default.
• W3142331256 hasConcept C61174792 @default.
• W3142331256 hasConcept C67018056 @default.
• W3142331256 hasConcept C71924100 @default.
• W3142331256 hasConcept C86803240 @default.
• W3142331256 hasConceptScore W3142331256C126322002 @default.
• W3142331256 hasConceptScore W3142331256C134018914 @default.
• W3142331256 hasConceptScore W3142331256C169760540 @default.
• W3142331256 hasConceptScore W3142331256C170493617 @default.
• W3142331256 hasConceptScore W3142331256C192118531 @default.
• W3142331256 hasConceptScore W3142331256C24998067 @default.
• W3142331256 hasConceptScore W3142331256C2777499176 @default.
• W3142331256 hasConceptScore W3142331256C61174792 @default.
• W3142331256 hasConceptScore W3142331256C67018056 @default.
• W3142331256 hasConceptScore W3142331256C71924100 @default.
• W3142331256 hasConceptScore W3142331256C86803240 @default.
• W3142331256 hasLocation W31423312561 @default.
• W3142331256 hasLocation W31423312562 @default.
• W3142331256 hasLocation W31423312563 @default.
• W3142331256 hasLocation W31423312564 @default.
• W3142331256 hasLocation W31423312565 @default.
• W3142331256 hasOpenAccess W3142331256 @default.
• W3142331256 hasPrimaryLocation W31423312561 @default.
• W3142331256 hasRelatedWork W1938254948 @default.
• W3142331256 hasRelatedWork W1986933516 @default.
• W3142331256 hasRelatedWork W1998832524 @default.
• W3142331256 hasRelatedWork W2091034365 @default.
• W3142331256 hasRelatedWork W2106490583 @default.
• W3142331256 hasRelatedWork W2148769969 @default.
• W3142331256 hasRelatedWork W2199889657 @default.
• W3142331256 hasRelatedWork W2251145129 @default.
• W3142331256 hasRelatedWork W2283351813 @default.
• W3142331256 hasRelatedWork W2890860159 @default.
• W3142331256 isParatext "false" @default.
• W3142331256 isRetracted "false" @default.
• W3142331256 magId "3142331256" @default.
• W3142331256 workType "article" @default.